Form4.ai tracks every SEC insider trade in real time. See every BRVE insider filing with a free account — no card.
See every BRVE insider filing — free account, no card.
Free accountBraveheart Bio, Inc. (BRVE) has 14 SEC Form 4 insider filings on record in the last 90 days. That includes 10 insider purchases totalling $159.0M. Most recent filing: Aug. 11, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Aug 11, 2026 SEC filing | AH Bio Fund IV, L.P. 10% Owner | Bought | $19,800,000 | +63.4% 30D |
| Aug 11, 2026 SEC filing | Chimovits Erez Director Same trade as ORBIMED ADVISORS LLC | Bought | $34,920,000 | +63.4% 30D |
| Aug 10, 2026 SEC filing | Jiangsu Hengrui Pharmaceuticals Co., Ltd. 10% Owner | Conversion | — | — |
Create a free account to see all 14 BRVE filings from the last 90 days. No card needed.
Create free accountWant BRVE insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.